Insulin Syringe Dead Space and Small-Volume Peptide Math

Dead space is the fluid volume that can remain in a syringe or needle path after the plunger is fully depressed. For small-volume peptide math, the useful question is not “what is the universal dead-space number?” but “how was this syringe measured, and how large is the residual volume relative to the draw being considered?”

This is a volume-and-measurement reference, not a dosing or injection recommendation.

What dead space means

Dead space describes the residual internal volume in the syringe system. ISO 8537 includes a normative annex titled “Test method for determination of dead space.” (ISO 8537:2016 preview)

The standard’s measurement method is more useful than an unsourced universal value because dead space is a property of a particular syringe-and-needle configuration. This page does not assign a microliter value to a brand or model that has not been measured in the evidence package.

Why the relative effect grows as the draw shrinks

U-100 is a volume scale calibrated at 100 units per mL. (ISO 8537:2007; see also the PeptideClock calculator rule)

For a fixed residual volume, the simple relative-error relationship is:

relative effect = dead-space volume ÷ draw volume

Both quantities are volumes, so the ratio is dimensionless. If the dead-space volume stays fixed while the draw becomes smaller, the residual volume represents a larger fraction of that draw. This is arithmetic about volume proportions, not a claim that a specific syringe loses a fixed percentage of a peptide dose.

A measurement worksheet

Record	Why it matters	Limit
Syringe and needle configuration	Dead space belongs to the complete syringe system being examined	Do not transfer a result to an unmeasured configuration
Nominal barrel scale	Establishes the volume scale used for the calculation	A U-100 mark is a volume reference, not peptide mass or a recommended target
Dead-space test method	Makes the measurement reproducible and auditable; ISO 8537 specifies a test method	The standard’s existence does not supply a value for every model
Measured or documented residual volume	Provides the numerator for a relative-volume calculation	Do not invent a value when the configuration has not been measured
Draw volume	Provides the denominator for the relative-volume calculation	Smaller draws make a fixed residual volume a larger fraction; this does not quantify clinical impact

The worksheet’s job is to keep device facts, measured values, and arithmetic separate. It is not a ranking of syringe brands and does not establish that one device is more accurate, repeatable, or suitable for human use than another.

Keep U-100 markings in their lane

ISO 8537 describes syringes for U-40 and U-100 insulin concentrations; the U-100 designation is the 100-units-per-mL scale. In PeptideClock’s calculation model, the unit divisor is also 100 units per mL. Marked units therefore provide a volume conversion. They do not automatically provide peptide mass, international units, potency, or a target amount.

For the scale relationship, use the U-100 insulin syringe reference. For concentration and target-amount arithmetic, see Concentration vs dose errors and the Peptide Calculator. Those tools keep the concentration assumption visible; dead-space discussion cannot replace it.

What this evidence does not establish

The sources support a definition, a standards-based test-method reference, and the arithmetic of relative volume. They do not support a universal dead-space value, a brand comparison, a fixed percentage loss, or a clinical conclusion about a particular draw. They also do not turn a volume marking into a peptide dose.

If a measurement is important to a study, record the exact syringe configuration, method, observed value, and limitations. If the configuration or method is unknown, state that uncertainty instead of filling it with a generic number.

Bottom line

Dead space is a measurable residual volume, not a universal percentage. ISO 8537 provides a dead-space test-method reference, U-100 provides a 100-units-per-mL volume scale, and the ratio of a fixed residual volume to the draw grows as the draw shrinks. Keep those three facts separate from concentration, peptide identity, and any clinical or dosing conclusion.

For research-only context and site boundaries, see the PeptideClock disclaimer.

---

References & Evidence

1. ISO 8537:2016 sample PDF — Annex D identifies the normative test method for determination of syringe dead space.
2. ISO 8537:2007 — standard scope covering U-40 and U-100 insulin syringes; U-100 is the 100-units-per-mL scale used in the site’s volume math.
3. PeptideClock calculation model — docs/calculator.md and src/utils/peptideCalculator.ts — site rule using 100 units per mL for U-100 volume conversion.